Elapharma SRL
Elapharma reported total assets of 236,353 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026).
The score of Elapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +134 % Total assets +114 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Elapharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jul 2026
- Year ended 31 Dec 2024filed on 25 May 2025
- Year ended 31 Dec 2023filed on 22 Apr 2024
- Year ended 31 Dec 2022filed on 06 Apr 2023
Elapharma's financial analysis
- Solvency72.1%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Elapharma
Elapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0785.990.208
- VAT number
- BE0785990208
- Peppol
- Registered · 0208:0785990208 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 May 2022
- Registered office
- 1020 Brussels
- Latest accounts
- 2025 · filed on 27 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Elapharma (SRL) has been based in Brussels since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 35,928 € and equity of 170,318 €; its revenue is not published. Its solvency stands at 72.1%, above the median of its sector (37.8%).
Companies similar to Elapharma
Companies in the same business, of comparable size and area, outside its group.
- DVL Retail sale of pharmaceutical products Dilbeek · balance sheet 235,408 €
- Pharmacie Keereman Retail sale of pharmaceutical products Schaerbeek · balance sheet 235,291 €
- SyGoBioClin Retail sale of pharmaceutical products Kraainem · balance sheet 235,248 €
- Apoteek DE Decker Retail sale of pharmaceutical products Lebbeke · balance sheet 234,587 €
- Lorophar Retail sale of pharmaceutical products Lincent · balance sheet 234,299 €
- Apotheek VAN Hoecke Retail sale of pharmaceutical products Kortrijk · balance sheet 234,019 €
- Sapos Retail sale of pharmaceutical products Aalst · balance sheet 241,792 €
- Pharmaphie EVG Retail sale of pharmaceutical products Evergem · balance sheet 229,312 €
Frequently asked questions about Elapharma
What is the revenue of Elapharma?
Elapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Elapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0785990208 for Elapharma, if the company is VAT-registered. Its company number (CBE) is 0785.990.208.
Where is the registered office of Elapharma?
According to the CBE register, the registered office of Elapharma is in 1020 Brussels.
What is the equity of Elapharma?
At the close of the 2025 financial year, the equity of Elapharma amounts to 170,318 €, a solvency of 72.1% of total assets.
Who manages Elapharma?
The register lists 1 active mandates at Elapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Elapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →